1. Home
  2. NEPH vs SLGL Comparison

NEPH vs SLGL Comparison

Compare NEPH & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • SLGL
  • Stock Information
  • Founded
  • NEPH 1997
  • SLGL 1997
  • Country
  • NEPH United States
  • SLGL Israel
  • Employees
  • NEPH N/A
  • SLGL N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • SLGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEPH Health Care
  • SLGL Health Care
  • Exchange
  • NEPH Nasdaq
  • SLGL Nasdaq
  • Market Cap
  • NEPH 36.1M
  • SLGL 19.3M
  • IPO Year
  • NEPH 2004
  • SLGL 2018
  • Fundamental
  • Price
  • NEPH $3.65
  • SLGL $8.14
  • Analyst Decision
  • NEPH Buy
  • SLGL Buy
  • Analyst Count
  • NEPH 1
  • SLGL 1
  • Target Price
  • NEPH $5.00
  • SLGL $40.00
  • AVG Volume (30 Days)
  • NEPH 65.9K
  • SLGL 25.4K
  • Earning Date
  • NEPH 08-07-2025
  • SLGL 08-15-2025
  • Dividend Yield
  • NEPH N/A
  • SLGL N/A
  • EPS Growth
  • NEPH N/A
  • SLGL N/A
  • EPS
  • NEPH 0.08
  • SLGL N/A
  • Revenue
  • NEPH $15,517,000.00
  • SLGL $12,103,000.00
  • Revenue This Year
  • NEPH $17.06
  • SLGL N/A
  • Revenue Next Year
  • NEPH $12.20
  • SLGL $31.17
  • P/E Ratio
  • NEPH $47.45
  • SLGL N/A
  • Revenue Growth
  • NEPH 10.34
  • SLGL 603.66
  • 52 Week Low
  • NEPH $1.36
  • SLGL $3.34
  • 52 Week High
  • NEPH $5.00
  • SLGL $16.50
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 50.89
  • SLGL 63.80
  • Support Level
  • NEPH $3.83
  • SLGL $6.96
  • Resistance Level
  • NEPH $4.25
  • SLGL $7.48
  • Average True Range (ATR)
  • NEPH 0.40
  • SLGL 0.28
  • MACD
  • NEPH -0.10
  • SLGL 0.07
  • Stochastic Oscillator
  • NEPH 19.35
  • SLGL 95.88

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Share on Social Networks: